Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -23.45% is 74% above its 5-year average of -91.61%, near the high end of its 5-year range (-169.83%–-23.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 77.36% above its 12-month average of -103.57%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -23.45%.
RETURN ON INVESTED CAPITAL (ROIC)
-23.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-103.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-89.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-91.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+77.36%
CURRENT VS 3Y AVG
+73.84%
CURRENT VS 5Y AVG
+74.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 743 covered companies
CURRENT VS SECTOR MEDIAN
+30.47%
vs the sector median at left
Phathom Pharmaceuticals, Inc.
Market Cap
$538.80M
Return on Invested Capital (ROIC)
-23.45%
TTM Avg
-103.57%
3Y Avg
-89.65%
5Y Avg
-91.61%
Market Cap
$538.61M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
Market Cap
$534.64M
Return on Invested Capital (ROIC)
-78.31%
TTM Avg
-49.75%
3Y Avg
-41.99%
5Y Avg
-101.04%
Market Cap
$545.19M
Return on Invested Capital (ROIC)
-317.86%
TTM Avg
-177.04%
3Y Avg
-169.25%
5Y Avg
-196.25%
Market Cap
$550.22M
Return on Invested Capital (ROIC)
-43.41%
TTM Avg
-39.91%
3Y Avg
-39.91%
5Y Avg
-39.91%
Market Cap
$541.20M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-66.45%
3Y Avg
-57.50%
5Y Avg
-60.06%
Market Cap
$527.70M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
Market Cap
$522.73M
Return on Invested Capital (ROIC)
-16.89%
TTM Avg
-20.74%
3Y Avg
-75.97%
5Y Avg
-65.59%
Market Cap
$517.30M
Return on Invested Capital (ROIC)
-19.47%
TTM Avg
-57.88%
3Y Avg
-52.57%
5Y Avg
-47.02%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | $538.80M | -23.45% | -103.57% | -89.65% | -91.61% |
| Delcath Systems, Inc. (DCTH)vs › | $538.61M | -0.81% | -8.59% | -110.96% | -102.03% |
| ProKidney Corp. (PROK)vs › | $534.64M | -78.31% | -49.75% | -41.99% | -101.04% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $545.19M | -317.86% | -177.04% | -169.25% | -196.25% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $550.22M | -43.41% | -39.91% | -39.91% | -39.91% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $541.20M | -56.99% | -66.45% | -57.50% | -60.06% |
| Immix Biopharma, Inc. (IMMX)vs › | $527.70M | -18.20% | -95.31% | -87.63% | -71.60% |
| Monopar Therapeutics Inc. (MNPR)vs › | $522.73M | -16.89% | -20.74% | -75.97% | -65.59% |
| Altimmune, Inc. (ALT)vs › | $517.30M | -19.47% | -57.88% | -52.57% | -47.02% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
ROIC
-23.5%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -23.45% |
| 2026-03-31 | -53.64% |
| 2025-12-31 | -125.87% |
| 2025-09-30 | -145.06% |
| 2025-06-30 | -169.83% |
| 2025-03-31 | -130.07% |
| 2024-12-31 | -94.83% |
| 2024-09-30 | -89.49% |
| 2024-06-30 | -92.81% |
| 2024-03-31 | -66.19% |
| 2023-12-31 | -44.61% |
| 2023-09-30 | -67.64% |
| 2023-06-30 | -61.99% |
| 2023-03-31 | -127.05% |
| 2022-12-31 | -124.44% |
| 2022-09-30 | -88.71% |
| 2022-06-30 | -77.66% |
| 2022-03-31 | -101.27% |
| 2021-12-31 | -79.22% |
| 2021-09-30 | -77.02% |
| 2021-06-30 | -82.98% |
| 2021-03-31 | -63.77% |
| 2020-12-31 | -50.89% |
| 2020-09-30 | -42.50% |
| 2020-06-30 | -25.88% |
| 2020-03-31 | -48.34% |
| 2019-12-31 | -41.91% |
| 2019-06-30 | -258.47% |
| 2018-12-31 | -184.49% |
